Revenue for Bio-Techne (TECH)
According to Bio-Techne's latest reported financial statements, the company's current revenue (TTM) is $1.22B USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
TECH
Currently viewingRevenueSwitch metric
TTM (last 4 quarters)
$1.22B
YoY change
+5.2%
5Y CAGR
+10.5%
Peak year (2025)
$1.22B
Cumulative revenue
$12.95B
Revenue history chart for Bio-Techne (TECH) from 1989 to 2025
Revenue history table for Bio-Techne (TECH) from 1989 to 2025
| Fiscal year | Period ended | Reported | Revenue | YoY |
|---|---|---|---|---|
| 2025 | $1.22B | +5.2% | ||
| 2024 | $1.16B | +2.0% | ||
| 2023 | $1.14B | +2.8% | ||
| 2022 | $1.11B | +18.7% | ||
| 2021 | $931.03M | +26.0% | ||
| 2020 | $738.69M | +3.5% | ||
| 2019 | $714.01M | +11.0% | ||
| 2018 | $642.99M | +14.2% | ||
| 2017 | $563.00M | +12.8% | ||
| 2016 | $499.02M | +10.3% | ||
| 2015 | $452.25M | +26.4% | ||
| 2014 | $357.76M | +15.2% | ||
| 2013 | $310.57M | -1.3% | ||
| 2012 | $314.56M | +8.5% | ||
| 2011 | $289.96M | +7.8% | ||
| 2010 | $269.05M | +1.9% | ||
| 2009 | $263.96M | +2.5% | ||
| 2008 | $257.42M | +15.2% | ||
| 2007 | $223.48M | +10.3% | ||
| 2006 | $202.62M | +13.4% | ||
| 2005 | $178.65M | +10.8% | ||
| 2004 | $161.26M | +11.2% | ||
| 2003 | $145.01M | +10.8% | ||
| 2002 | $130.90M | +13.5% | ||
| 2001 | $115.36M | +11.1% | ||
| 2000 | $103.84M | +14.2% | ||
| 1999 | $90.90M | +35.1% | ||
| 1998 | $67.30M | +10.5% | ||
| 1997 | $60.90M | +11.5% | ||
| 1996 | $54.60M | +14.5% | ||
| 1995 | $47.70M | +18.4% | ||
| 1994 | $40.30M | +40.4% | ||
| 1993 | $28.70M | +28.7% | ||
| 1992 | $22.30M | +15.5% | ||
| 1991 | $19.30M | +22.9% | ||
| 1990 | $15.70M | +25.6% | ||
| 1989 | $12.50M | — |
Revenue values are taken from Bio-Techne's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Bio-Techne (TECH) revenue totalled $1.22B – grew 5.2% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Bio-Techne revenue compounded at +10.5% per year, sustaining 12 straight years of year-over-year growth.
$1.22B stands as the all-time-high annual revenue, posted in 2025, against a low of $12.50M during 1989.
Bio-Techne (TECH) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $65.09B.
Bio-Techne Revenue by Year
Bio-Techne Revenue 2025: $1.22B
Bio-Techne revenue in 2025 was $1.22B, grew 5.2% from 2024. This figure represents the highest annual value in the available history.
Bio-Techne Revenue 2024: $1.16B
Bio-Techne revenue in 2024 was $1.16B, edged up 2.0% from 2023.
Bio-Techne Revenue 2023: $1.14B
Bio-Techne revenue in 2023 was $1.14B, edged up 2.8% from 2022.
Bio-Techne Revenue 2022: $1.11B
Bio-Techne revenue in 2022 was $1.11B, grew 18.7% from 2021.
Bio-Techne Revenue 2021: $931.03M
Bio-Techne revenue in 2021 was $931.03M.
See more financial history for Bio-Techne (TECH).
Sector peers — Revenue
Companies in the same sector as Bio-Techne, ranked by their latest revenue.
| Company | Revenue | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $447.57B | Healthcare |
| Novo Nordisk A/S (NVO) | $309.06B | Healthcare |
| Johnson & Johnson (JNJ) | $94.19B | Healthcare |
| Eli Lilly and Company (LLY) | $65.18B | Healthcare |
| Merck & Co., Inc. (MRK) | $65.01B | Healthcare |
| AbbVie Inc. (ABBV) | $61.16B | Healthcare |
| AstraZeneca PLC (AZN) | $58.74B | Healthcare |
| Amgen Inc. (AMGN) | $36.74B | Healthcare |
Frequently asked questions
What is Bio-Techne's revenue?
- Latest reported revenue for Bio-Techne (TECH) is $1.22B (period ending December 31, 2025).
How has Bio-Techne revenue changed year-over-year?
- Bio-Techne (TECH) revenue changed +5.2% year-over-year on the latest annual filing.
What is the long-term growth rate of Bio-Techne revenue?
- Bio-Techne (TECH) revenue compound annual growth rate is +10.5% over the most recent 5 years available.
When did Bio-Techne revenue hit its highest annual value?
- Bio-Techne revenue reached its highest annual value of $1.22B in 2025.
What was Bio-Techne revenue in 2024?
- Bio-Techne (TECH) revenue in 2024 was $1.16B.
What was Bio-Techne revenue in 2025?
- Bio-Techne (TECH) revenue in 2025 was $1.22B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
TECH Overview
Company profile, financial tools, and key metrics
TECH Revenue Counter
Earns $38.55 every second. See per minute, hour, and day.
TECH Earnings Counter
Earns $2.57 per second net profit. See per minute, hour, and day.
TECH Economic Scale
Exceeds Samoa's GDP. Compare with world economies.
TECH What If Invested
What if you had invested $1,000? See historical returns from any date.
TECH How It Makes Money
Discover visual breakdown of $1.22B in revenue — where it comes from and where it goes.
TECH Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
TECH Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
TECH Daily Price Character
Balanced · 45.3% historical win rate (green days). Streaks & record days.
TECH Buybacks
2.18% TTM buyback yield. Shareholder yield & SBC comparison.
TECH Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.
TECH Dividend Profile
Yield: 0.62%. Safety: 5/8. See full history.
TECH Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
TECH Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.